Animal models and therapeutic molecules

Patent metadata

Field	Value
Publication number	US-9505827-B2
Application number	US-201313740727-A
Country	US
Kind code	B2
Filing date	Jan 14, 2013
Priority date	Jul 8, 2009
Publication date	Nov 29, 2016
Grant date	Nov 29, 2016

Abstract

The invention discloses methods for the generation of chimaeric human-non-human antibodies and chimaeric antibody chains, antibodies and antibody chains so produced, and derivatives thereof including fully humanized antibodies; compositions comprising said antibodies, antibody chains and derivatives, as well as cells, non-human mammals and vectors, suitable for use in said methods.

First claim

The invention claimed is:

1. A transgenic mouse having a germline with a homozygous immunoglobulin heavy chain (IgH) locus comprising unrearranged human IgH variable region gene segments comprising Vs, Ds and Js at an endogenous locus operatively linked to an IgH constant (C) region comprising an endogenous C segment at an IgH locus;
wherein said homozygous IgH locus comprises in 5′ to 3′ transcriptional orientation said unrearranged human Vs, Ds and Js comprising a 3′ JH gene segment, a human/mouse chimeric DNA junction, an enhancer, and said operatively linked C region;
wherein said homozygous chimeric IgH locus comprises a chimeric J/C intron comprising human DNA downstream of and naturally contiguous with said 3′ JH gene segment, said human DNA being contiguous with mouse J/C intronic DNA upstream of said enhancer, and wherein said human DNA joins said mouse J/C intronic DNA at said human/mouse chimeric junction within said J/C intron,
wherein DNA between said 3′ human JH segment and said human/mouse chimeric DNA junction is less than 2 kb,
said germline comprising all or part of mouse IgH variable region DNA; wherein said homozygous IgH locus of said mouse is capable of undergoing V, D, J joining; wherein said transgenic mouse is capable, upon stimulation with antigen, of producing antibody comprising a chimeric Ig heavy chain comprising a human IgH variable region; and wherein said transgenic mouse is capable of breeding with a second transgenic mouse, said second transgenic mouse having a germline with a homozygous IgH locus comprising unrearranged human IgH variable region gene segments operatively linked to an IgH constant (C) region comprising an endogenous C segment of an IgH locus to provide subsequent generation mice, wherein a said subsequent generation mouse comprises:
(a) in its germline an homozygous IgH locus comprising unrearranged human IgH variable region gene segments operatively linked to an IgH constant (C) region comprising an endogenous C segment of an IgH locus, and
(b) in its germline all or part of mouse IgH variable region DNA; and
(c) wherein said IgH locus of said subsequent generation mouse is capable of undergoing V, D, J joining;
(d) wherein said subsequent generation mouse is capable, upon stimulation with antigen, of producing antibody comprising a chimeric Ig heavy chain comprising a human IgH variable region; and
(e) is capable of breeding with a mouse having a germline with a homozygous IgH locus comprising unrearranged human IgH variable region gene segments operatively linked to an IgH constant (C) region comprising an endogenous C segment of an IgH locus to provide further subsequent generation mice.

2. The mouse of claim 1 , wherein said mouse J/C intronic DNA at said human/mouse chimeric junction and upstream of said enhancer comprises 129 mouse strain DNA, and wherein said enhancer is a mouse 129 strain μ enhancer.

3. The transgenic mouse of claim 1 , wherein DNA between said 3′ human JH gene segment and said human/mouse chimeric DNA junction is less than 1 kb.

4. The mouse of claim 1 , wherein said C gene segment comprises a mouse Cμ segment.

5. The transgenic mouse of claim 1 , wherein said all or part of said mouse IgH variable region DNA is away from its native position in an IgH locus.

6. The transgenic mouse of claim 5 , wherein said all or part of said mouse IgH variable region DNA is inverted with respect to its native chromosomal orientation and upstream of said human variable region gene segments.

7. The transgenic mouse of claim 2 , wherein said unrearranged human VH gene segments are in the place of endogenous mouse Ig VH region segment(s) upstream of said enhancer.

8. The transgenic mouse of claim 2 , wherein said unrearranged human DH gene segments are in the place of endogenous mouse Ig DH gene segment(s) upstream of said enhancer.

9. The transgenic mouse of claim 2 , wherein said unrearranged human JH gene segments are in the place of endogenous mouse Ig JH gene segment(s) upstream of said enhancer.

10. The transgenic mouse of claim 1 , wherein said human DNA contiguous with said human 3′ JH gene segment comprises 400 base pairs of human JC intron DNA.

Assignees

• Kymab Ltd

Inventors

• Bradley Allan
• Lee E-Chiang
• Liang Qi
• Wang Wei
• Friedrich Glenn

Classifications

• C07K16/18 Primary

  against material from animals or humans · CPC title

• A01K67/0275

  Genetically modified vertebrates, e.g. transgenic · CPC title

• C07K16/1239

  from Vibrionaceae (G) · CPC title

• A01K2267/01

  Animal expressing industrially exogenous proteins · CPC title

• C07K16/462

  Igs containing a variable region (Fv) from one specie and a constant region (Fc) from another · CPC title